澳洲幸运5官方开奖结果体彩网

Intuitive Surgical Stock Jumps After Q1 Earnings Beat Amid da Vinci Robotic System Growth

Monitor This Key Chart Level

This image depicts the ISRG chart.
Source: TradingView.com.

Key Takeaways

  • Intuitive Surgical shares jumped moved more than 3% higher in late trade Thursday after the medical devices maker surpassed analysts first-quarter earnings and sales estimates.
  • The company's robotic da Vinci platform saw year-over-year global procedure growth of 16%, while its next generation da Vinci 5 robotic system received FDA clearance in March.
  • The Intuitive Surgical share price may face resistance around $403 from a a trendline linking three recent price peaks.

Shares in Intuitive Surgical (ISRG) jumped mo♈re than 3% in after-hours Thursday after surpassing analysts’ earnings and revenue forecasts amid growing demand for the company’s robotics solutions used in minimally invasive medical procedures.

For the three months ending March 31, the medical devices maker posted 澳洲幸运5官方开奖结果体彩网:adjusted earnings of $1.50 per share, easily topping Wall Street’s estimate of $1.41 a share. Revenue of $1.89 billion in the period grew 11% and also came in ahead of forecasts, which analysts had pegged at $1.87 billion.

The top line was boosted from the company’s instruments and accessories business, which saw sales jump 18% from a year earlier, primarily due to 16% growth in da Vinci procedure volume, 90% growth in Ion procedure volume, and favorable pricing. The 澳洲幸运5官方开奖结果体彩网:medical equipment maker’s robotic da Vinci platform assists surgeons’ precision and control when performing minimally invasive surgery, and the Ion procedure is a robot-assisted biopsy..

The company highlighted its next generation da Vinci 5 robotic system, saying it received 澳洲幸运5官方开奖结果体彩网:Food and Drug Administration (FDA) clearance in March and that the company had placed eight of the systems by the end of the quarter.

Growing demand for robotics assisted procedures indicated by Intuitive Surgical on Thursday echoes remarks by rival Johnson & Johnson (JNJ) earlier this week when it reported 澳洲幸运5官方开奖结果体彩网:first-quarter earnings, saying that it expects medical technology-related procedure volumes to remain elevated through 2024.

Intuitive Surgical shares moved higher for several months after the 50-day moving average crossed above the 200-day moving average in late December to generate a 澳洲幸运5官方开奖结果体彩网:golden cross buy signal but have remained 澳洲幸运5官方开奖结果体彩网:rangebound since early March. Amid follow-through buying after the company’s better-than-expected earnings report, investors should monitor the $403 level, a location on the chart where the stock may run into 澳洲幸运5官方开奖结果体彩网:resistance from a trendl🧜ine linking three recent price peaks.

The comments, opinions, and analyses expressed on Investopedia are for informational purposes only. Read our 澳洲幸运5官方开奖结果体彩网:warranty and liability disclaimer for more info.

As of the date this article was written, the author does not own any of the above securities.

Do you have a news tip for Investopedia reporters? Please email us at
Article Sources
Investopedia requires writers to use primary sources to support their work. These include white papers, government data, original reporting, and interviews with industry experts. We also reference original research from other reputable publishers where appropriate. You can learn more about the standards we follow in producing accurate, unbiased content in our editorial policy.
  1. Intuitive Surgical. "."

  2. Reuters. "."

  3. Intuitive Surgical. "."

  4. Johnson & Johnson. "."

Compare Accounts
The offers that appear in this table are from partnerships from which Investopedia receives compensation. This compensation may impact how and where listings appear. Investopedia does not include all offers available in the marketplace.

Related Articles